CVS HEALTH Corp·4

Apr 4, 4:24 PM ET

Chaguturu Sreekanth K 4

4 · CVS HEALTH Corp · Filed Apr 4, 2023

Insider Transaction Report

Form 4
Period: 2023-04-01
Chaguturu Sreekanth K
EVP and Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2023-04-01$74.31/sh1,854$137,7716,427.633 total
  • Award

    Stock Option

    2023-04-01$74.31/sh+40,825$3,033,70640,825 total
    Exercise: $74.31From: 2024-04-01Exp: 2033-04-01Common Stock (40,825 underlying)
Holdings
  • Common Stock (Restricted)

    21,972
  • Stock Option

    Exercise: $75.27From: 2020-11-29Exp: 2029-11-29Common Stock (5,952 underlying)
    5,952
  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01Common Stock (9,502 underlying)
    9,502
  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01Common Stock (9,579 underlying)
    9,579
  • Stock Option

    Exercise: $101.09From: 2023-04-01Exp: 2032-04-01Common Stock (12,993 underlying)
    12,993
Footnotes (6)
  • [F1]Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award.
  • [F2]Option became exercisable in four equal annual installments, commencing 11/29/2020.
  • [F3]Option became exercisable in four equal annual installments, commencing 4/1/2021.
  • [F4]Option became exercisable in four equal annual installments, commencing 4/1/2022.
  • [F5]Option became exercisable in four equal annual installments, commencing 4/1/2023.
  • [F6]Option becomes exercisable in four equal annual installments, commencing 4/1/2024.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT